Update of Coronavirus's impact on Vitrolife's sales
Vitrolife estimates that sales during the first quarter will be approximately in line with last year in local currency and that the EBITDA margin will amount to approximately 33-37 percent. Furthermore, the company assess that the second quarter will be significantly negatively impacted by the virus outbreak.In the beginning of March, Vitrolife estimated that sales in the Asia region will decrease by approximately 30 percent in local currency during the first quarter and that other regions will not materially be affected. As the virus has spread outside Asia, negative effects of sales can